Background Myasthenia gravis (MG) leads to exertion-dependent muscle weakness, but
also psychological and social well-being are limited. We aim to describe the burden of …

Objective Myasthenia gravis (MG) people experience adverse psychiatric outcomes, which
may impact on their life and disturb their daily activity. Depression and anxiety are identified …

Myasthenia gravis (MG) is a type of muscle paralysis created by immune responses against
acetylcholine receptor proteins in neuromuscular synapses. This disease is characterized by …

Introduction Myasthenia gravis (MG) is a neuromuscular disease causing extreme muscular
fatigue, triggering problems with vision, swallowing, speech, mobility, dexterity, and …

Objectives Myasthenia gravis (MG) is a rare, chronic, autoimmune neuromuscular disease
which can affect functional and mental aspects of health and health-related quality of life …

Introduction Myasthenia gravis (MG) is a rare neuromuscular disorder marked by a variable
combination of weakness of eye, bulbar, respiratory, axial, and limb muscles. This study …

Objectives Patients who are victims of a mild stroke are vulnerable to several invisible and
neglected neurological sequelae. In parallel, it is known that fatigue and neuropsychiatric …

Objective Better understanding the impact of social determinants of health (SDOH) barriers
from the patient perspective is crucial to improve holistic patient support in generalized …

Background Myasthenia gravis (MG) is a rare autoimmune disease and chronic condition
that necessitates specialized care. Patients experience a significant burden of disease …

Background The environmental effects on the prognosis of ocular myasthenia gravis (OMG)
remain largely unexplored. Aim To investigate the association between specific …